Skip to main content

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

DAWN holding history

Day One Biopharmaceuticals, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DAWN overviewAll 13F holders of DAWNFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q3 2022
Holdings of DAWN by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−819,371−100.0%Sold outHolders
Q1 2026819,371$17.6M<0.1%−217,941−21.0%ReducedHolders
Q4 20251,037,312$9.67M<0.1%−185,972−15.2%ReducedHolders
Q3 20251,223,284$8.62M<0.1%−193,269−13.6%ReducedHolders
Q2 20251,416,553$9.21M<0.1%+113,588+8.7%AddedHolders
Q1 20251,302,965$10.3M<0.1%+375,948+40.6%AddedHolders
Q4 2024927,017$11.7M<0.1%+90,822+10.9%AddedHolders
Q3 2024836,195$11.6M<0.1%−51,922−5.8%ReducedHolders
Q2 2024888,117$12.2M<0.1%−93,455−9.5%ReducedHolders
Q1 2024981,572$16.2M<0.1%+203,655+26.2%AddedHolders
Q4 2023777,917$11.4M<0.1%+471,732+154.1%AddedHolders
Q3 2023306,185$3.76M<0.1%+123,007+67.2%AddedHolders
Q2 2023183,178$2.19M<0.1%−180,881−49.7%ReducedHolders
Q1 2023364,059$4.87M<0.1%+225,451+162.7%AddedHolders
Q4 2022138,608$2.98M<0.1%+87,200+169.6%AddedHolders
Q3 202251,408$1.03M<0.1%+51,408NewHolders